First Trust Advisors LP Biomarin Pharmaceutical Inc Transaction History

First Trust Advisors LP

  • $101 Billion
  • Q3 2024

A detailed history of First Trust Advisors LP transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, First Trust Advisors LP holds 467,298 shares of BMRN stock, worth $30 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
467,298
Previous 404,024 15.66%
Holding current value
$30 Million
Previous $33.3 Million 1.25%
% of portfolio
0.03%
Previous 0.04%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
BUY
$69.02 - $93.84 $4.37 Million - $5.94 Million
63,274 Added 15.66%
467,298 $32.8 Million
Q2 2024

Aug 13, 2024
SELL
$74.43 - $92.22 $5.4 Million - $6.69 Million
-72,507 Reduced 15.22%
404,024 $33.3 Million
Q1 2024

May 13, 2024
SELL
$83.81 - $99.0 $8.67 Million - $10.2 Million
-103,400 Reduced 17.83%
476,531 $41.6 Million
Q4 2023

Feb 13, 2024
BUY
$76.22 - $98.51 $4.31 Million - $5.57 Million
56,532 Added 10.8%
579,931 $55.9 Million
Q3 2023

Nov 13, 2023
BUY
$85.07 - $94.48 $1.48 Million - $1.65 Million
17,438 Added 3.45%
523,399 $46.3 Million
Q2 2023

Aug 14, 2023
BUY
$86.68 - $100.3 $1.05 Million - $1.21 Million
12,099 Added 2.45%
505,961 $43.9 Million
Q1 2023

May 15, 2023
SELL
$87.74 - $117.27 $724,907 - $968,884
-8,262 Reduced 1.65%
493,862 $48 Million
Q4 2022

Feb 09, 2023
SELL
$80.93 - $108.63 $4.3 Million - $5.78 Million
-53,169 Reduced 9.57%
502,124 $52 Million
Q3 2022

Nov 14, 2022
SELL
$82.16 - $96.94 $3.54 Million - $4.17 Million
-43,066 Reduced 7.2%
555,293 $47.1 Million
Q2 2022

Aug 12, 2022
SELL
$71.48 - $86.85 $378,057 - $459,349
-5,289 Reduced 0.88%
598,359 $49.6 Million
Q1 2022

May 13, 2022
SELL
$74.28 - $92.69 $38.7 Million - $48.3 Million
-521,126 Reduced 46.33%
603,648 $46.5 Million
Q4 2021

Feb 08, 2022
BUY
$71.72 - $91.47 $3 Million - $3.83 Million
41,888 Added 3.87%
1,124,774 $99.4 Million
Q3 2021

Nov 15, 2021
SELL
$74.77 - $85.47 $9.94 Million - $11.4 Million
-132,988 Reduced 10.94%
1,082,886 $83.7 Million
Q2 2021

Aug 16, 2021
BUY
$75.51 - $84.79 $6.51 Million - $7.31 Million
86,213 Added 7.63%
1,215,874 $101 Million
Q1 2021

May 14, 2021
BUY
$74.73 - $90.69 $22.4 Million - $27.1 Million
299,286 Added 36.04%
1,129,661 $85.3 Million
Q4 2020

Feb 02, 2021
SELL
$72.61 - $90.2 $13.4 Million - $16.6 Million
-184,481 Reduced 18.18%
830,375 $72.8 Million
Q3 2020

Nov 05, 2020
SELL
$71.87 - $131.03 $9.34 Million - $17 Million
-129,950 Reduced 11.35%
1,014,856 $77.2 Million
Q2 2020

Jul 22, 2020
BUY
$79.55 - $124.22 $30.9 Million - $48.2 Million
387,808 Added 51.23%
1,144,806 $141 Million
Q1 2020

May 06, 2020
SELL
$71.37 - $96.85 $7.79 Million - $10.6 Million
-109,093 Reduced 12.6%
756,998 $64 Million
Q4 2019

Feb 03, 2020
BUY
$64.27 - $86.37 $569,817 - $765,756
8,866 Added 1.03%
866,091 $73.2 Million
Q3 2019

Nov 04, 2019
SELL
$67.4 - $85.11 $26.4 Million - $33.3 Million
-391,836 Reduced 31.37%
857,225 $57.8 Million
Q2 2019

Jul 30, 2019
SELL
$80.35 - $93.9 $1.03 Million - $1.21 Million
-12,847 Reduced 1.02%
1,249,061 $107 Million
Q1 2019

May 09, 2019
BUY
$84.2 - $98.62 $14.7 Million - $17.2 Million
174,499 Added 16.05%
1,261,908 $112 Million
Q4 2018

Feb 07, 2019
SELL
$80.14 - $106.07 $11.2 Million - $14.9 Million
-140,091 Reduced 11.41%
1,087,409 $92.6 Million
Q3 2018

Oct 25, 2018
BUY
$93.92 - $105.72 $49.2 Million - $55.4 Million
523,649 Added 74.4%
1,227,500 $119 Million
Q2 2018

Aug 02, 2018
BUY
$76.01 - $99.03 $6.65 Million - $8.66 Million
87,468 Added 14.19%
703,851 $66.3 Million
Q1 2018

Apr 23, 2018
BUY
$77.67 - $92.63 $2.37 Million - $2.83 Million
30,545 Added 5.21%
616,383 $50 Million
Q4 2017

Feb 08, 2018
BUY
$80.76 - $95.13 $880,284 - $1.04 Million
10,900 Added 1.9%
585,838 $52.2 Million
Q3 2017

Oct 24, 2017
BUY
$80.6 - $94.95 $46.3 Million - $54.6 Million
574,938
574,938 $53.5 Million

Others Institutions Holding BMRN

# of Institutions
636
Shares Held
178M
Call Options Held
2.01M
Put Options Held
1.28M
View Full List

About BIOMARIN PHARMACEUTICAL INC

BMRN Quotes by TradingView
  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $11.9B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track First Trust Advisors LP Portfolio

Follow First Trust Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Trust Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on First Trust Advisors LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email